aim
establish
system
monitor
activ
gproteincoupl
receptor
gpcr
use
enzym
fragment
complement
efc
technolog
method
two
inact
delet
fragment
bla
bla
b
fuse
gpcr
respect
stabl
cell
line
name
express
two
fusion
protein
gpcrbla
b
gener
antibiot
select
natur
compound
librari
high
perform
liquid
chromatographi
hplc
fraction
sampl
ethanol
extract
chines
medicin
herb
use
highthroughput
screen
ht
agonist
cell
line
interest
hit
valid
measur
secondmesseng
cyclic
adenosin
monophosph
camp
product
result
stabl
cell
line
respond
agonistantagonist
dosedepend
manner
ec
valu
obtain
isoproterenol
nmoll
ic
valu
obtain
propranolol
nmoll
furthermor
ht
perform
identifi
agonist
natur
compound
librari
establish
factor
valu
determin
three
hit
identifi
primari
screen
found
potent
isoproterenol
camp
assay
conclus
cellbas
highthroughput
function
assay
establish
directli
monitor
activ
gpcr
base
interact
agonistactiv
gpcr
use
efc
technolog
use
search
lead
natur
compound
librari
gproteincoupl
receptor
gpcr
largest
known
famili
transmembran
receptor
bind
transduc
signal
huge
varieti
endogen
ligand
involv
physiolog
function
metabol
neuron
transmiss
embryon
develop
hormon
homeostasi
cancer
invas
current
market
drug
target
gpcr
develop
new
technolog
gpcrbase
drug
discoveri
promis
keep
field
activ
year
come
recent
sever
cellbas
drug
discoveri
strategi
develop
use
surrog
marker
gpcr
function
ubiquit
express
cell
tissu
bind
high
affin
agonistactiv
gpcr
carboxyltermin
tail
assay
develop
base
interact
transfluor
assay
bioluminesc
reson
energi
transfer
assay
assay
tango
assay
wide
use
investig
mani
gpcr
achiev
demonstr
monitor
interact
offer
direct
indic
gpcr
activ
describ
cellbas
proteinprotein
interact
assay
base
complement
technolog
use
gpcr
protein
partner
monitor
gpcr
activ
enzym
fragment
complement
efc
assay
pioneer
properti
provid
signific
advantag
mammalian
cell
monomer
rel
small
express
mani
differ
cell
type
divers
cellular
compart
addit
endogen
activ
highli
sensit
cellperm
fluoresc
substrat
also
offer
great
potenti
quantif
result
intact
cell
research
success
appli
system
monitor
gpcr
activ
two
inact
delet
fragment
bla
bla
b
fuse
gpcr
respect
two
fragment
complement
recov
activ
agonistpromot
interact
gpcr
recoveri
activ
determin
cellperm
fluoresc
substrat
demonstr
gpcr
activ
studi
chose
model
typic
gpcr
thoroughli
character
agonist
wide
use
agent
treatment
asthma
owe
bronchodil
action
chines
medicin
herb
use
treat
mani
diseas
demonstr
effect
thousand
year
lab
establish
natur
compound
librari
contain
high
perform
liquid
chromatographi
hplc
fraction
sampl
ethanol
extract
chines
medicin
herb
librari
success
use
find
inhibitor
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
agonist
dopamin
receptor
follow
describ
detail
applic
efc
assay
monitor
gpcr
activ
screen
agonist
natur
compound
librari
construct
isoproterenol
propranolol
purchas
sigma
st
loui
usa
obtain
invitrogen
carlsbad
ca
usa
plasmid
construct
gene
fragment
bla
bla
b
amplifi
ligas
vector
clontech
mountain
view
ca
usa
primer
use
forward
primer
bla
bla
b
revers
primer
bla
bla
b
flexibl
g
linker
insert
front
fragment
human
cdna
without
stop
codon
clone
front
fragment
bla
bla
b
respect
gener
b
two
express
vector
primer
use
forward
primer
revers
primer
cell
cultur
stabl
cell
line
select
cell
maintain
dulbecco
modifi
eagl
medium
dmem
invitrogen
carlsbad
ca
usa
supplement
fetal
bovin
serum
mmoll
lglutamin
stabl
cell
line
gener
cotransfect
two
express
construct
b
cell
cell
select
addit
gl
cultur
medium
isol
cell
clone
perform
stimul
cellular
clone
isoproterenol
clone
turn
green
blue
fluoresc
microscopi
detect
individu
isol
perform
assay
cell
load
accord
dye
provid
protocol
incub
room
temperatur
min
flexstat
ii
molecular
devic
sunnyval
ca
usa
use
determin
bluegreen
ratio
set
excit
nm
emiss
nm
blue
fluoresc
nm
green
fluoresc
bluegreen
ratio
calcul
follow
manufactur
instruct
inductioninhibit
receptor
cell
cellswel
seed
black
matrigelco
micropl
clearbottom
cultur
h
agonist
dose
respons
cell
incub
isoproterenol
serumfre
dmem
min
antagonist
dose
respons
cell
first
preincub
min
serumfre
dmem
contain
differ
concentr
propranolol
room
temperatur
isoproterenol
ad
incub
anoth
min
load
perform
assay
bluegreen
ratio
determin
flexstat
ii
imag
captur
fluoresc
microscopi
olympu
tokyo
japan
herbal
plant
therapeut
indic
collect
herb
market
anguo
hebei
china
briefli
dri
chines
herb
dissolv
ethanol
h
sonic
h
remain
soak
ethanol
h
extract
h
ethanol
extract
filter
lyophil
product
lyophil
redissolv
ethanol
high
perform
liquid
chromatographi
hplc
isol
total
gradient
obtain
hplc
isol
chines
herb
extract
gradient
lyophil
dissolv
dimethyl
sulfoxid
dmso
kept
freezer
data
present
statist
signific
evalu
student
ttest
differ
consid
statist
signific
p
z
factor
calcul
describ
previous
zhang
et
al
concentrationrespons
determin
curv
fit
calcul
ec
ic
use
graphpad
prism
softwar
studi
gpcr
activ
efc
assay
stabl
cell
line
establish
cotransfect
plasmid
encod
human
b
two
fusion
construct
figur
select
describ
materi
method
cell
clone
best
signal
background
ratio
chosen
name
clone
b
two
fusion
construct
highli
express
two
delet
mutant
bla
bla
b
individu
inact
low
affin
ligand
stimul
caus
conform
chang
recruit
cell
membran
interact
brought
two
inact
fragment
togeth
reconstitut
function
enzym
recoveri
activ
determin
assay
direct
indic
agonistinduc
gpcr
activ
via
recruit
figur
agonist
stimul
cell
coexpress
b
caus
complement
two
fragment
reconstitut
hydrolyz
substrat
emit
blue
fluoresc
excit
nm
gener
blue
fluoresc
cell
could
attribut
activ
gproteincoupl
receptor
figur
top
agonist
effect
could
inhibit
antagonist
propranolol
preincub
propranolol
percentag
cell
emit
blue
fluoresc
agonist
stimul
similar
untreat
cell
figur
middl
bottom
dose
respons
curv
isoproterenol
propranolol
also
calcul
use
graphpad
prism
softwar
shown
figur
cell
respond
known
agonist
isoproterenol
dosedepend
increas
activ
ec
valu
isoproterenol
found
nmoll
similar
previous
report
data
cell
nmoll
use
isoproterenolstimul
sequestr
assay
also
data
obtain
cell
nmoll
use
base
efc
assay
dosedepend
inhibit
demonstr
treatment
antagonist
propranolol
presenc
isoproterenol
figur
ic
nmoll
obtain
propanolol
use
efc
assay
also
consist
report
data
see
cellbas
assay
suitabl
highthroughput
screen
z
factor
valu
calcul
describ
previous
zhang
et
al
half
plate
treat
isoproterenol
half
plate
untreat
four
well
design
reagent
control
calcul
bluegreen
ratio
demonstr
activ
z
factor
experi
figur
assess
valu
cell
model
search
agonist
target
screen
hplcfraction
sampl
ethanol
extract
chines
medicin
herb
format
isoproterenol
use
posit
control
dmso
use
neg
control
cell
incub
well
treat
ident
contain
dmso
concentr
determin
advers
effect
cell
assay
data
shown
fraction
activ
express
percentag
maxim
induct
isoproterenol
shown
figur
three
fraction
exhibit
signific
effect
induct
activ
effect
fraction
induct
complement
also
shown
figur
fraction
activ
three
time
standard
deviat
consid
insignific
confirm
activ
primari
screen
hit
repeat
interact
assay
triplic
figur
fraction
identifi
maximum
induct
fraction
show
maximum
induct
three
posit
hit
valid
melanocortin
receptor
cell
line
also
gener
base
complement
assay
expect
agonist
effect
cell
line
figur
classic
gproteincoupl
receptor
use
investig
ligand
bind
receptor
chang
conform
coupl
heterotrimer
gprotein
result
elev
camp
level
thu
hit
obtain
primari
screen
also
valid
anoth
function
assay
measur
induct
camp
express
shown
figur
three
fraction
nearli
intens
camp
induct
posit
control
isoproterenol
two
experi
confirm
effect
three
fraction
activ
three
posit
fraction
consecut
obtain
fructu
aurantii
immaturu
hplc
chromatogram
fraction
shown
figur
addit
methyl
thiazolyl
tetrazolium
mtt
test
show
fraction
treatment
test
result
suggest
cellbas
function
assay
system
base
complement
technolog
high
select
agonist
identif
use
tool
highthroughput
screen
monitor
gpcr
activ
establish
cellbas
highthroughput
screen
assay
system
monitor
gproteincoupl
receptor
activ
use
complement
technolog
detect
activ
recoveri
could
observ
imag
intact
cell
fluoresc
microscop
system
also
adapt
sort
analyz
flow
cytometri
two
fragment
kda
kda
rel
smaller
mani
tag
protein
size
decreas
possibl
alter
function
chimer
fusion
protein
small
size
monomer
characterist
avail
cellperm
fluoresc
substrat
suggest
system
base
enzym
complement
wide
potenti
biolog
studi
drug
discoveri
gpcr
activ
lead
signal
transduct
two
mediat
gprotein
agonist
bind
gpcr
activ
heterotrimer
gprotein
activ
promot
secondmesseng
signal
subsequ
regul
differ
physiolog
function
anoth
pathway
gpcr
signal
transduct
mediat
activ
receptor
phosphoryl
gproteincoupl
receptor
kinas
recruit
termin
signal
transduct
gprotein
receptor
move
clathrinco
pit
cell
membran
caus
receptor
intern
desensit
meanwhil
also
serv
scaffold
numer
signal
molecul
stimul
receptor
agonist
initi
second
parallel
set
signal
tradit
thought
ligand
bind
stimul
inhibit
receptor
function
equal
extent
recent
year
research
found
bias
ligand
mani
gpcr
perfect
bias
ligand
stimul
one
receptor
activ
without
stimul
known
receptor
activ
develop
ligand
might
provid
opportun
novel
therapi
cellbas
model
provid
tool
measur
agonistpromot
interact
gpcr
along
assay
measur
secondmesseng
product
exampl
ca
camp
model
remain
promis
search
bias
ligand
specif
gpcr
signal
pathway
activ
gproteinor
signal
transduct
tradit
chines
medicin
herb
effect
treatment
mani
diseas
studi
screen
tradit
chines
medicin
herb
librari
hit
could
activ
recruit
caus
complement
fragment
three
hit
found
fraction
sampl
valid
measur
camp
product
three
herbal
extract
possibl
agonist
summari
achiev
demonstr
cellbas
assay
use
complement
technolog
suitabl
ligand
screen
assay
also
valid
two
gpcr
melanocortin
receptor
dopamin
receptor
data
shown
approach
may
provid
altern
strategi
scientist
interest
area
